UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Kynurenines in the CNS: recent advances and new questions

Nature reviews. Drug discovery, 2013-01, Vol.12 (1), p.64-82

2013

Volltextzugriff (PDF)

Exploiting the Therapeutic Potential of Endogenous Immunomodulatory Systems in Multiple Sclerosis-Special Focus on the Peroxisome Proliferator-Activated Receptors (PPARs) and the Kynurenines

International journal of molecular sciences, 2019-01, Vol.20 (2), p.426

2019

Volltextzugriff (PDF)

Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathy

Journal of Neural Transmission, 2020-06, Vol.127 (6), p.963-972

2020

Volltextzugriff (PDF)

Investigational α-synuclein aggregation inhibitors: hope for Parkinson's disease

Expert opinion on investigational drugs, 2016-11, Vol.25 (11), p.1281-1294

2016

Volltextzugriff (PDF)

Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets

Journal of Alzheimer's disease, 2014-01, Vol.42 Suppl 3 (s3), p.S177-S187

2014

Volltextzugriff (PDF)

Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders

Journal of the neurological sciences, 2012-11, Vol.322 (1), p.187-191

2012

Volltextzugriff (PDF)

Association of vitamin D receptor gene polymorphisms and Parkinson's disease in Hungarians

Neuroscience letters, 2013-09, Vol.551, p.70-74

2013

Volltextzugriff (PDF)

Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunction

Current topics in medicinal chemistry, 2012-08, Vol.12 (16), p.1797-1806

2012

Volltextzugriff (PDF)

The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal Diagnosis

Journal of Alzheimer's disease, 2016-07, Vol.53 (2), p.373-392

2016

Volltextzugriff (PDF)

Drug-induced movement disorders

Expert opinion on drug safety, 2015-06, Vol.14 (6), p.877-890

2015

Volltextzugriff (PDF)

A longitudinally extensive H3 K27M-mutant diffuse midline glioma in an elderly patient clinically mimicking central nervous system inflammation: a case report

Folia neuropathologica, 2021, Vol.58 (4), p.377-385

2021

Volltextzugriff (PDF)

PACAP and its role in primary headaches

Journal of headache and pain, 2018-03, Vol.19 (1), p.21-7, Article 21

2018

Volltextzugriff (PDF)

Alzheimer’s Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines

Journal of Alzheimer's disease, 2018-01, Vol.62 (2), p.523-547

2018

Volltextzugriff (PDF)

Non-motor Behavioral Alterations of PGC-1α-Deficient Mice - A Peculiar Phenotype With Slight Male Preponderance and No Apparent Progression

Frontiers in behavioral neuroscience, 2018-08, Vol.12, p.180-180

2018

Volltextzugriff (PDF)

Central nervous system-specific alterations in the tryptophan metabolism in the 3-nitropropionic acid model of Huntington's disease

Pharmacology, biochemistry and behavior, 2015-05, Vol.132, p.115-124

2015

Volltextzugriff (PDF)

Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi’s Concept (Szeged) till Novel Approaches to Boost Mitochondrial Bioenergetics

Oxidative medicine and cellular longevity, 2015-01, Vol.2015 (2015), p.1-19

2015

Volltextzugriff (PDF)

Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012-2015)

Expert opinion on therapeutic patents, 2016-07, Vol.26 (7), p.815-832

2016

Volltextzugriff (PDF)

Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson’s disease

Journal of Neural Transmission, 2013-04, Vol.120 (4), p.673-681

2013

Volltextzugriff (PDF)

mRNA Expression Levels of PGC-1α in a Transgenic and a Toxin Model of Huntington’s Disease

Cellular and molecular neurobiology, 2015-03, Vol.35 (2), p.293-301

2015

Volltextzugriff (PDF)

Histopathological comparison of Kearns-Sayre syndrome and PGC-1α-deficient mice suggests a novel concept for vacuole formation in mitochondrial encephalopathy

Folia neuropathologica, 2016-01, Vol.54 (1), p.9-22

2016

Volltextzugriff (PDF)

High-dose 1,25-dihydroxyvitamin D supplementation elongates the lifespan of Huntington's disease transgenic mice

Acta neurobiologiae experimentalis, 2016-01, Vol.76 (3), p.176-181

2016

Volltextzugriff (PDF)

Additional value of tau protein measurement in the diagnosis of Creutzfeldt-Jakob disease

Ideggyógyászati szemle, 2019-01, Vol.72 (1-2), p.39-47

2019

Volltextzugriff (PDF)

Manipulating Kynurenic Acid Levels in the Brain – On the Edge Between Neuroprotection and Cognitive Dysfunction

Current topics in medicinal chemistry, 2012-11, Vol.12 (16), p.1797-1806

2012

Volltextzugriff (PDF)

Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis

Reviews in the neurosciences, 2021-08, Vol.32 (6), p.573-595

2021

Volltextzugriff (PDF)

Clinicopathological Relationships in an Aged Case of DOORS Syndrome With a p.Arg506X Mutation in the ATP6V1B2 Gene

Frontiers in neurology, 2020-08, Vol.11

2020

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(28)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Kynurenines in the CNS: recent advances and new questions

Exploiting the Therapeutic Potential of Endogenous Immunomodulatory Systems in Multiple Sclerosis-Special Focus on the Peroxisome Proliferator-Activated Receptors (PPARs) and the Kynurenines

Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathy

Investigational α-synuclein aggregation inhibitors: hope for Parkinson's disease

Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets

Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders

Association of vitamin D receptor gene polymorphisms and Parkinson's disease in Hungarians

Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunction

The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal Diagnosis

Drug-induced movement disorders

A longitudinally extensive H3 K27M-mutant diffuse midline glioma in an elderly patient clinically mimicking central nervous system inflammation: a case report

PACAP and its role in primary headaches

Alzheimer’s Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines

Non-motor Behavioral Alterations of PGC-1α-Deficient Mice - A Peculiar Phenotype With Slight Male Preponderance and No Apparent Progression

Central nervous system-specific alterations in the tryptophan metabolism in the 3-nitropropionic acid model of Huntington's disease

Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi’s Concept (Szeged) till Novel Approaches to Boost Mitochondrial Bioenergetics

Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012-2015)

Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson’s disease

mRNA Expression Levels of PGC-1α in a Transgenic and a Toxin Model of Huntington’s Disease

Histopathological comparison of Kearns-Sayre syndrome and PGC-1α-deficient mice suggests a novel concept for vacuole formation in mitochondrial encephalopathy

High-dose 1,25-dihydroxyvitamin D supplementation elongates the lifespan of Huntington's disease transgenic mice

Additional value of tau protein measurement in the diagnosis of Creutzfeldt-Jakob disease

Manipulating Kynurenic Acid Levels in the Brain – On the Edge Between Neuroprotection and Cognitive Dysfunction

Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis

Clinicopathological Relationships in an Aged Case of DOORS Syndrome With a p.Arg506X Mutation in the ATP6V1B2 Gene

Suchergebnisse filtern